canSAR Publications


canSAR: an updated cancer research and drug discovery knowledgebase
Joseph E. Tym†, Costas Mitsopoulos†, Elizabeth A. Coker, Parisa Razaz, Amanda C. Schierz, Albert A. Antolin and Bissan Al-Lazikani
Nucl. Acids Res. (04 January 2016) 44 (D1): D938-D943. doi: 10.1093/nar/gkv1030
04/01/2016 Abstract Full Text PDF
Distinctive behaviors of druggable proteins in cellular networks
Costas Mitsopoulos, Amanda C. Schierz, Paul Workman, Bissan Al-Lazikani.
PLOS Computational Biology, 2015; 11 (12): e1004597 DOI: 10.1371/journal.pcbi.1004597
23/12/2015 Abstract Full Text PDF Additional Info
canSAR: updated cancer research and drug discovery knowledgebase
Krishna C. Bulusu, Joseph E. Tym, Elizabeth A. Coker, Amanda C. Schierz, and Bissan Al-Lazikani.
Nucleic Acids Research 2014; doi: 10.1093/nar/gkt1182
01/01/2014 Abstract Full Text PDF
Drugging cancer genomes
Paul Workman & Bissan Al-Lazikani
doi:10.1038/nrd4184
29/11/2013 Abstract Full Text PDF Additional Info
Objective Assessment of Cancer Genes for Drug Discovery
Mishal N. Patel, Mark D. Halling-Brown, Joseph E. Tym, Paul Workman and Bissan Al-Lazikani
doi: 10.1038/nrd3913
31/12/2012 Abstract Full Text PDF Additional Info
Combinatorial drug therapy for cancer in the post-genomic era
Bissan Al-Lazikani, Udai Banerji & Paul Workman
doi:10.1038/nbt.2284
10/07/2012 Abstract Full Text PDF
Personalized Medicine: Patient-Predictive Panel Power
Paul Workman, Paul A. Clarke, Bissan Al-Lazikani
doi: 10.1016/j.ccr.2012.03.030
16/04/2012 Abstract Full Text PDF
canSAR: an integrated cancer public translational research and drug discovery resource
Mark D. Halling-Brown; Krishna C. Bulusu; Mishal Patel; Joe E. Tym; Bissan Al-Lazikani
Nucleic Acids Research 2011; doi: 10.1093/nar/gkr881
19/10/2011 Abstract Full Text PDF